<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="6180">
  <stage>Registered</stage>
  <submitdate>13/08/2016</submitdate>
  <approvaldate>13/08/2016</approvaldate>
  <nctid>NCT02967107</nctid>
  <trial_identification>
    <studytitle>Cold Snare Polypectomy Versus Endoscopic Mucosal Resection for Colonic Sessile Serrated Polyps</studytitle>
    <scientifictitle>Cold Snare Polypectomy Versus Endoscopic Mucosal Resection for Colonic Sessile Serrated Polyps - A Randomised Controlled Trial</scientifictitle>
    <utrn />
    <trialacronym>CSP-EMR</trialacronym>
    <secondaryid>HREC/15/WMEAD/507</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Colorectal Cancer</healthcondition>
    <healthcondition>Adenoma</healthcondition>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Bowel - Back passage (rectum) or large bowel (colon)</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Other endocrine disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: surgery - Cold snare polypectomy
Treatment: surgery - Endoscopic mucosal resection

Active Comparator: Cold snare polypectomy - Cold snare resection, if necessary, multi-piece to resect sessile serrated adenoma (SSA) 8-20mm

Active Comparator: Endoscopic mucosal resection - Endoscopic mucosal resection (EMR), if necessary, multi-piece to resect sessile serrated adenoma (SSA) 8-20mm


Treatment: surgery: Cold snare polypectomy
Use of a polypectomy snare closed over a polyp without electrocautery

Treatment: surgery: Endoscopic mucosal resection
Use of injected chromogelofusine solution to raise a lesion prior to snare resection with electrocautery

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Number of participants with residual or recurrent adenoma as assessed at surveillance endoscopy</outcome>
      <timepoint>4-6 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Number of participants with bleeding after the EMR procedure has finished as assessed by telephone interview at 2 weeks</outcome>
      <timepoint>2 weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Number of participants with residual or recurrent adenoma as assessed at admission or telephone interview at 2 weeks</outcome>
      <timepoint>2 weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Number of participants with pain after EMR as assessed by VAS score and telephone interview at 2 weeks - Pain after EMR</outcome>
      <timepoint>2 weeks</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  - Patients able to give informed consent to involvement in trial. For patients who do
             not speak English, an interpreter will be asked to translate the informed consent

          -  Patients referred to Westmead and Auburn Hospital Endoscopy Unit for a colonoscopy for
             all indications

          -  Age &gt; 18 years

          -  At least one SSP 8-20 mm beyond the rectosigmoid junction without any endoscopic
             features of malignancy

          -  At least one SSP 8-20 mm beyond the rectosigmoid junction that according to the
             proceduralist, can be removed safely using either CSP or EMR</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Current use of antiplatelets (excluding aspirin) or anticoagulants which have not
             appropriately been interrupted according to the guidelines [21]

          -  Known coagulopathy

          -  Pregnancy

          -  If any doubt about the morphology of the polyp, the patient will be excluded from the
             study</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/08/2016</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>400</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>1/08/2019</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
    <hospital>Westmead Hospital - Westmead</hospital>
    <postcode>2145 - Westmead</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Western Sydney Local Health District</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>Comparing the efficacy of cold snare polypectomy with endoscopic mucosal resection</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT02967107</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Michael Bourke, MBBS</name>
      <address />
      <phone>00612 9633 5953</phone>
      <fax />
      <email>reception@citywestgastro.com.au</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>